Despite all the research happening around understanding Alzheimer’s disease in the past few decades, the reality is that scientists still don’t have great answers for struggling patients. This has led ...

NEW YORK--(BUSINESS WIRE)--Bonerge announced the initiation of its clinical trial, focusing on Fisetin, Urolithin A, and Ergothioneine. Involving 108 participants, this trial aims to evaluate their ...

A new research paper was published in Aging (Aging-US) on March 29, 2025, as the cover of Volume 17, Issue 3, titled "Differential senolytic inhibition of normal versus Aβ-associated cholinesterases: ...

A new pilot study known as STAMINA (Senolytics To Alleviate Mobility Issues and Neurological Impairments in Aging), that focused on the effects of senolytic medications, Dasatinib and Quercetin (DQ), ...

“This work provides new opportunities for the development of the next generation of ChE inhibitors that specifically target AChE and BChE associated with AD pathology.” “This work provides new ...

Geroscience examines the underlying biology of aging to delay chronic diseases and extend the healthy years of human life.

Finding new drugs—called "drug discovery"—is an expensive and time-consuming task. But a type of artificial intelligence called machine learning can massively accelerate the process and do the job for ...

ROCHESTER, Minn. — The presence of senescent or dysfunctional cells can make young mice age faster. And using senolytic drugs in elderly mice to remove these rogue cells can improve health and extend ...